MUMFER Tablet

Treatment of latent iron deficiency and iron deficiency anaemia. Prevention of iron and folic acid deficiency before, during and after pregnancy (during lactation).

For prophylactic therapy of iron deficiency to cover the recommended daily dietary allowances (RDA) during pregnancy & lactation.

Dosage & Administration

Dosage and duration of therapy are dependent upon the extent of iron deficiency.

The daily dose can be divided into separate doses or can be taken at one time.

Mumfer chewable tablets can be chewed or swallowed whole and should be taken during or immediately after a meal.

In cases of manifest iron deficiency the therapy takes 3-5 months until a normalization of the haemoglobin value is achieved.

Afterwards the therapy should be continued for several weeks with a dosage such as described for latent iron deficiency to replenish the iron stores.

Manifestation of iron deficiency: 1-3 tablets daily

Latent iron deficiency: 1 tablet daily.

Hypersensitivity to any ingredient of the formulation.

No interactions have been observed.

Since, the iron is complex bound, ionic interactions with foodstuff components (phytin, oxalates, tannin, etc.) and concomitant administration of medicaments (tetracyclins, antacids) are unlikely to occur.

Mumfer does not cause teeth staining.

The haemoccult-test (selective for haemoglobin) for the detection of occult blood is not impaired and therefore iron therapy must not be interrupted.

Iron (III) hydroxide polymaltose complex is non-toxic, due to the fact that an active transport of iron or a rate determining competitive ligand exchange instead of passive diffusion process is assumed to occur. In contrast, the absorption of Ferrous salts is not controlled by or a respective feedback mechanism, even in normal or iron-loaded subjects, and therefore, adverse drug reactions may occur especially when administering several doses a day.